GENE EXPRESSION AND KETAMINE RESPONSE IN SUBJECTS WITH TREATMENT RESISTANT DEPRESSION

被引：0
|
作者：
Sahra, Mohazzab-Hosseinian [1 ]
Pirooznia, Mehdi [2 ]
Zandi, Peter [3 ]
Goes, Fernando [3 ]
机构：
[1] Johns Hopkins Sch Publ Hlth, Baltimore, MD USA
[2] Johns Hopkins Sch Med, Baltimore, MD USA
[3] Johns Hopkins Univ, Baltimore, MD 21218 USA
来源：
EUROPEAN NEUROPSYCHOPHARMACOLOGY | 2019年 / 29卷
关键词：
D O I：
10.1016/j.euroneuro.2019.07.201
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
60
引用
收藏
页码：S93 / S93
页数：1
相关论文
共 50 条
  • [31] Ketamine-Associated Change in Anhedonia and mTOR Expression in Treatment-Resistant Depression
    Singh, Balwinder
    Voort, Jennifer L. Vande
    Riva-Posse, Patricio
    Pazdernik, Vanessa M.
    Frye, Mark A.
    Tye, Susannah J.
    BIOLOGICAL PSYCHIATRY, 2023, 93 (12) : E65 - E68
  • [32] Neurocognitive effects of ketamine in treatment-resistant major depression: association with antidepressant response
    James W. Murrough
    Le-Ben Wan
    Brian Iacoviello
    Katherine A. Collins
    Carly Solon
    Benjamin Glicksberg
    Andrew M. Perez
    Sanjay J. Mathew
    Dennis S. Charney
    Dan V. Iosifescu
    Katherine E. Burdick
    Psychopharmacology, 2014, 231 : 481 - 488
  • [33] Clinical and biological predictors of ketamine response in treatment-resistant major depression: Review
    Romeo, B.
    Choucha, W.
    Fossati, P.
    Rotge, J. -Y.
    ENCEPHALE-REVUE DE PSYCHIATRIE CLINIQUE BIOLOGIQUE ET THERAPEUTIQUE, 2017, 43 (04): : 354 - 362
  • [34] Oral ketamine for the treatment of pain and treatment-resistant depression
    Schoevers, Robert A.
    Chaves, Tharcila V.
    Balukova, Sonya M.
    aan het Rot, Marije
    Kortekaas, Rudie
    BRITISH JOURNAL OF PSYCHIATRY, 2016, 208 (02) : 108 - 113
  • [35] Change in Cytokine Levels is not Associated with Antidepressant Response to Ketamine in Patients with Treatment Resistant Depression
    Park, Minkyung
    Luckenbaugh, David A.
    Newman, Laura E.
    Niciu, Mark J.
    Lefler, Marc S.
    Machado-Vieira, Rodrigo
    Zarate, Carlos A.
    BIOLOGICAL PSYCHIATRY, 2016, 79 (09) : 69S - 70S
  • [36] Antisuicidal Response after Ketamine Infusion Is Associated with Reduced Wakefulness in Treatment Resistant Depression
    Voort, Jennifer L. Vande
    Ballard, Elizabeth D.
    Duncan, Wallace C.
    Luckenbaugh, David A.
    Richards, Erica M.
    Niciu, Mark J.
    Zarate, Carlos A.
    BIOLOGICAL PSYCHIATRY, 2015, 77 (09) : 130S - 130S
  • [37] Functional Connectivity and Response to Ketamine Therapy in Treatment-Resistant Depression: A Pilot Study
    Vasavada, Megha
    Leaver, Amber
    Loureiro, Joana
    Espinoza, Randall
    Joshi, Shantanu
    Njau, Stephanie
    Wade, Benjamin
    Kubicki, Antoni
    Congdon, Eliza
    Narr, Katherine
    BIOLOGICAL PSYCHIATRY, 2018, 83 (09) : S292 - S292
  • [38] Neurocognitive effects of ketamine in treatment-resistant major depression: association with antidepressant response
    Murrough, James W.
    Wan, Le-Ben
    Iacoviello, Brian
    Collins, Katherine A.
    Solon, Carly
    Glicksberg, Benjamin
    Perez, Andrew M.
    Mathew, Sanjay J.
    Charney, Dennis S.
    Iosifescu, Dan V.
    Burdick, Katherine E.
    PSYCHOPHARMACOLOGY, 2014, 231 (03) : 481 - 488
  • [39] D-serine plasma concentration is a potential biomarker of (R,S)-ketamine antidepressant response in subjects with treatment-resistant depression
    Ruin Moaddel
    David A. Luckenbaugh
    Ying Xie
    Alma Villaseñor
    Nancy E. Brutsche
    Rodrigo Machado-Vieira
    Anuradha Ramamoorthy
    Maria Paz Lorenzo
    Antonia Garcia
    Michel Bernier
    Marc C. Torjman
    Coral Barbas
    Carlos A. Zarate
    Irving W. Wainer
    Psychopharmacology, 2015, 232 : 399 - 409
  • [40] Biomarkers of the rapid clinical response to ketamine in treatment-resistant depression: focus on kynurenine
    Clarke, G.
    Naughton, M.
    O'Shea, R.
    Dowling, J.
    Walsh, A.
    Ismail, F.
    Shorten, G.
    Scott, L.
    Cryan, J. F.
    Dinan, T. G.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2014, 24 : S460 - S460
12345